News | Coronavirus (COVID-19) | May 31, 2023

People Coinfected with SARS-CoV-2 and Cytomegalovirus are at Increased Risk of Developing Cardiovascular Disease

Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide.

The researcher Alejandra Pera, in her office. Image courtesy of University of Córdoba. 

May 31, 2023 — Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide. Depending on the geographical area, it can affect between 40% and 90% of the population and, although it does not produce symptoms in healthy people, the control of this chronic infection requires constant work by the immune system, which is constantly fighting to keep it at bay. A study by the University of Cordoba (UCO) and Cordoba’s Maimonides Biomedical Research Institute (IMIBIC) evaluated the effect of SARS-CoV-2 coronavirus infection in patients who had mild or asymptomatic COVID-19, and who were also infected with cytomegalovirus. According to the results of this study, people coinfected with both pathogens present the premature aging of their immune systems, which is related to a greater risk of suffering cardiovascular disease at an earlier age. 

As the principal investigator on the study, Dr. Alejandra Pera, explains, this does not mean that people who have been infected with these two viruses will necessarily develop cardiovascular problems. However, given the prevalence of both viruses, it does represent one more circumstance "that should be taken into account in the patient's clinical history" and added to the list of other risk factors, such as alcohol and tobacco consumption, the regular intake of foods high in saturated fats, and a sedentary lifestyle.  


T-cells, in the Right Measure 

The study analyzed the state of the immune systems of people with and without chronic cytomegalovirus infection 3 and 12 months after mild or asymptomatic infection by SARS-CoV-2 (the coronavirus responsible for COVID-19). According to the results, in patients infected by both viruses, an expansion of T-cells with increased functionality is generated. These T cells are memory-endowed lymphocytes that are essential for our body's defense, but when their functions are excessively activated, they generate inflammation and can damage the vascular endothelium, a layer of cells that lines the inside of blood vessels. "Cytomegalovirus alone causes these cells to increase. Now we have found that SARS-CoV-2 has an added effect," the researcher adds.  

One of the most striking aspects of the study is that this effect was documented in people who were infected with even mild or asymptomatic forms of the coronavirus. The scientific community is studying the effects to a greater extent in patients with severe symptoms, "but we are seeing that COVID-19 also has medium- and long-term consequences in people who had the disease without complications, and that we should take this into account", emphasized the study's lead author. 

Vaccines as Prevention 

The study, whose first author is UCO predoctoral researcher Pablo Álvarez, showed that after infection with SARS-CoV-2 there is an increase in cells associated with cardiovascular disease in patients previously infected with cytomegalovirus. In those individuals who became ill with COVID after having been vaccinated, however, this phenomenon does not occur. 
Although Dr. Pera stressed that further studies should be conducted to take into account the effect of the different waves and variants of the coronavirus, the results seem to indicate that the vaccines prevent and mitigate this uncontrolled expansion of T cells capable of doing cardiovascular damage.  

For more information: 


Related COVID-19 Content: 

FDA Clears Third COVID-19 Vaccine From Janssen 

FDA Clears First COVID-19 Vaccine Under an Emergency Use Authorization 

FDA Approved Second COVID-19 Vaccine From Moderna 

Cardiologists Should Prioritize Influenza Vaccination Amidst COVID-19 Pandemic 

Who Qualifies for the COVID Vaccine Under CDC Guidelines 

Cardiology related COVID news and video 

FDA Clears First COVID-19 Vaccine Under an Emergency Use Authorization 

VIDEO: Lingering Myocardial Involvement After COVID-19 Infection — Interview with Aaron Baggish, M.D. 

COVID-19 Can Impact Hearts in Young Children 

COVID-19 Positive STEMI Patients Have Higher Mortality  

VIDEO: ECMO Hemodynamic Support Effective in Sickest COVID-19 Patients — Interview with Ryan Barbaro, M.D. 

The Cardiovascular Impact of COVID-19 

COVID-19 Cardiovascular Registry Details Disparities Among Hospitalized Patients 

VIDEO: How to Reduce COVID Exposure, Speed Exams and Cut Readmissions in Cardiology Departments— Interview with Keith Ellis, M.D., 

COVID-19 Patients With Cardiovascular Disease Have In-hospital Mortality Rates of 25 to 38 Percent 

Kawasaki-like Inflammatory Disease Affects Children With COVID-19 

VIDEO: What Are The Long-term Cardiac Impacts of COVID-19 Infection — Interview with Todd Hurst, M.D. 

VIDEO: Overview of Multisystem Inflammatory Syndrome in Children (MIS-C) in COVID-19 Exposed Children 

Case Study Describes One of the First U.S. Cases of MIS-C 

Find more cardiology related COVID content 

Related Content

Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home June 12, 2024
News | Cardiovascular Clinical Studies

June 6, 2024 —Cleveland Clinic researchers found higher amounts of the sugar alcohol xylitol are associated with ...

Home June 06, 2024
News | Cardiovascular Clinical Studies

May 31, 2024 — CareDx, a leading precision medicine company focused on the discovery, development, and commercialization ...

Home May 31, 2024
News | Cardiovascular Clinical Studies

May 29, 2024 — Data was presented by AstraZeneca on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL ...

Home May 29, 2024
News | Cardiovascular Clinical Studies

May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that ...

Home May 23, 2024
News | Cardiovascular Clinical Studies

May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first findings ...

Home May 23, 2024
News | Cardiovascular Clinical Studies

May 21, 2024 — A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging ...

Home May 21, 2024
News | Cardiovascular Clinical Studies

May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians have ...

Home May 20, 2024
News | Cardiovascular Clinical Studies

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...

Home May 18, 2024
Subscribe Now